Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRPL30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZDHHC13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EEF1D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRCH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506282 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAOX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ZC3H15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNHG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORD96A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
U2SURP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XPO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMURF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on